The biotechnology sector is about to see some major shifts as patents expire and M&A activity gathers steam. Exchange traded funds (ETFs) are one of the best ways to get exposure to this dynamic and unpredictable sector. Speculating on biotech mergers and acquisitions is about as solid a...